181 related articles for article (PubMed ID: 3662275)
1. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
Malloy MJ; Kane JP; Kunitake ST; Tun P
Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427
[TBL] [Abstract][Full Text] [Related]
3. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
[TBL] [Abstract][Full Text] [Related]
4. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
Zambon A; Hokanson JE; Brown BG; Brunzell JD
Circulation; 1999 Apr; 99(15):1959-64. PubMed ID: 10208998
[TBL] [Abstract][Full Text] [Related]
6. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
Illingworth DR
Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
[TBL] [Abstract][Full Text] [Related]
7. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
8. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
Simons LA; Simons J; Parfitt A
Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
[TBL] [Abstract][Full Text] [Related]
9. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
10. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
Schrott HG; Stein EA; Dujovne CA; Davidson MH; Goris GB; Oliphant TH; Phillips JC; Shawaryn GG
Am J Cardiol; 1995 Jan; 75(1):34-9. PubMed ID: 7801861
[TBL] [Abstract][Full Text] [Related]
11. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy of niacin, colestipol, and fat-controlled diet in men with coronary bypass. Effect on blood lipids and apolipoproteins.
Nessim SA; Chin HP; Alaupovic P; Blankenhorn DH
Arteriosclerosis; 1983; 3(6):568-73. PubMed ID: 6651612
[TBL] [Abstract][Full Text] [Related]
13. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
Weisweiler P
Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia.
Tonstad S; Ose L; Gørbitz C; Harrison EM; de Koning Gans HJ
Scand J Clin Lab Invest; 1993 Aug; 53(5):457-63. PubMed ID: 8210967
[TBL] [Abstract][Full Text] [Related]
15. Use of niacin, statins, and resins in patients with combined hyperlipidemia.
Brown BG; Zambon A; Poulin D; Rocha A; Maher VM; Davis JW; Albers JJ; Brunzell JD
Am J Cardiol; 1998 Feb; 81(4A):52B-59B. PubMed ID: 9526815
[TBL] [Abstract][Full Text] [Related]
16. Regression of tendon xanthomas in patients with familial hypercholesterolemia treated with lovastatin.
Illingworth DR; Cope R; Bacon SP
South Med J; 1990 Sep; 83(9):1053-7. PubMed ID: 2402652
[TBL] [Abstract][Full Text] [Related]
17. Probucol with colestipol in the treatment of hypercholesterolemia.
Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
[TBL] [Abstract][Full Text] [Related]
18. Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis.
Brown BG
Eur Heart J; 1992 Jul; 13 Suppl B():17-20. PubMed ID: 1644095
[TBL] [Abstract][Full Text] [Related]
19. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
Vega GL; Grundy SM
JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
[TBL] [Abstract][Full Text] [Related]
20. Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease.
Brown BG; Bardsley J; Poulin D; Hillger LA; Dowdy A; Maher VM; Zhao XQ; Albers JJ; Knopp RH
Am J Cardiol; 1997 Jul; 80(2):111-5. PubMed ID: 9230143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
